Review Article

The Battle between Virus and Host: Modulation of Toll-Like Receptor Signaling Pathways by Virus Infection

Table 1

Molecular mechanisms involved in modulation of host innate immune systems by viruses.

Virus/Virus proteinHost pathwayFunctionEffect

RNA virus

Human immunodeficiency virus (HIV)
 NefTCR-CD30Inhibit NF-κB and AP-1 activationInhibit T cell activation
TLR4Inhibit ERK activation (Dephosphorylation of ERK by induced MKP-1)Suppress TNF-α production
 VpuTLRsInhibit NF-κB activation (Stabilize IκB)Suppress cytokine production
 TatActivate NF-κB (PKR-dependent)
 VprActivate NF-κBEnhance IL-6, IL-8, and IL-10 production
 RNA40TLR7/8Activate IRF-7 mediated by MyD88Activate pDCs

Human T-lymphotropic leukemia virus 1 (HTLV-1)
 p30TLR4Suppress TLR4 expression (Suppress PU.1 fuction)Suppress cytokine production
Inhibit GSK3-βEnhance IL-10 production
 p12TCRSuppress phosphorylation of PLC-γ1 and VavSuppress T cell activation by DCs
 TaxActivate IKK (Bind to IKKγ)Induce IL-2, IL-2R, GM-CSF, and IL-15

Hepatitis C virus (HCV)
 NS3/4ATLR3/4Degrade TRIFSuppress IFN-α/β production
Suppress CD4+ T cell activation by dysfunction of mDCs
 NS5ATLRsInhibit NF-κB activation (Bind to MyD88)Suppress cytokine production
Inhibit JNK activation (Bind to TRAF2)Suppress TNF pathway activation
 core, NS3TLR2Activate MAP kinase pathway, NF-κB, and AP-1Dysfunction of pDCs by enhanced production of IL-10 and TNF-  α  

Measles virus
 N (?)Suppress IL-12 production mediated by TLR4 in DCs (Suppress Th1 differentiation)
 PTLR2/4Suppress NF-κB and AP-1 activation (Upregulate host NF-κB negative regulator A20)Inhibit proinflammatory cytokine and chemokine production
 HATLR2Activate NF-κBInduce cytokine production

Influenza virus A
 NS1TLR3/7/9Suppress of IRF3/7 activationInhibit IFN production in pDC
TLR4Suppress of NF-κB and AP-1 activationSuppress DC and T cell activation
RIG-ISuppress of IRF3/7 activationInhibit IFN production in mDC
SARS-coronavirus (SARS-CoV)
NActivate AP-1
Bind  to NF-κB  and  C/EBP binding motifs of IL-6 promoter
Induce IL-6 and COX-2

promoter

Human respiratory syncytial virus (RSV)
 GTLR2/4/9Suppress NF-κB activationSuppress cytokine production
 FTLR4Activate NF-κBInduce IL-1, IL-6, IL-8, and RANTES
 M2-1Activate NF-κB
 ?TLR7/9Suppress IFN production in pDC
 NS1, NS2TLR3/4, RIG-ISuppress IRF3 activationSuppress IFN production in mDC

Rotavirus
 VP4Activate NF-κB
Suppress JNK (Bind  to  TRAF2)

DNA virus

  Vaccinia virus
 A46RTLRsSuppress NF-κB activation (Bind to MyD88, TRAM, and TRIF)Suppress cytokine production
 A52RTLRsSuppress NF-κB activation (Bind to IRAK2)Suppress cytokine production
Activate p38 MAPK and JNK (Bind to TRAF6)Induce IL-10 production
 N1LTLRsSuppress NF-κB activation (Bind to IKKγ)Suppress cytokine production
Suppress IRF3 activation (Bind to TBK1)Suppress IFN production

  Adenovirus
 RIDTLR4Suppress NF-κB and AP-1 activationSuppress MCP-1 and IL-8 production
TNF pathwaySuppress TNFR1 expressionSuppress MCP-1 and IL-8 production
 capsidActivate NF-κB, ERK, and MAPKInduce RANTES and IL-10

  Herpes simplex virus (HSV)
 virionTLR2Induce cytokine production
 viral DNATLR9Induce IFN production

 Varicella-zoster virus
 vrionTLR2Induce cytokine production

  Human cytomegalovirus (HCMV)
 late proteinsIL-1 systemSuppress NF-κB activation (Inhibit site located upstream of MAP3K)
TNF systemSuppress TNFR1 expression
 gB/gHTLR2/1Activate NF-κBProduce proinflammatory cytokines
  Epstein-Barr virus (EBV)
 late proteinSuppress NF-κB activationInhibit COX-2 activation
 gp350/gp220TLR2/CD21Activate NF-κBInduce MCP-1 production
 LMP-1Activate p38 MAPK (TRAF6-dependent)Suppress DC function by induced IL-10

  Human herpesvirus 8 (HHV8)
 vFLIPActivate IKK
(Bind to IKKγ)

 RTADegrade IRF7 by proteasome systemSuppress IFN-α/β production

  Hepatitis B virus
 e antigenIL-1 pathwayActivate NF-κBInduce cytokine
(Bind to mIL-1RAcP) production